The Belgian Health Care Knowledge Centre (KCE) is launching 2 new calls for clinical trials:
- KCE Trials Long COVID fast-track call (deadline for submission 15th June 2021) involving clinical studies on treatment modalities for patients with long-term effects of COVID-19.
- KCE Trials 2021 investigator-led call (deadline for submission 14th September 2021) involving clinical studies which show comparative effectiveness and clear value for money by a potential return on investment.
What and for who?
The KCE Trials programme focuses on pragmatic and practice-oriented clinical studies which show comparative effectiveness and clear value for money by a potential return on investment. Those studies compare two treatment options (with ‘no treatment’ being one of the possible treatment options) that are already in use in clinical practice in a given indication, but are not yet sufficiently directly compared (i.e. which of the two treatment options work best in daily practice). Accepted study interventions are not limited to drugs or medical devices but also include a broad range of interventions, such as psychotherapy, diet, diagnostic tests, surgery or ways to deliver health care.
Investigators who submit a research proposal will have the support of the Clinical Trial Unit (CTU) of Health, Innovation and Research Institute (HIRUZ) to perform the proposed clinical trial.
For more information and support, please contact HIRUZ CTU via Hélène De Naeyer (Helene.email@example.com or 09/332.05.05).